![](/img/cover-not-exists.png)
300 Preclinical pharmacologic characterization of GSK2849330, a monoclonal AccretaMab® antibody with optimized ADCC and CDC activity directed against HER3
Clarke, N., Hopson, C., Hahn, A., Sully, K., Germaschewski, F., Yates, J., Akinseye, C., Mangatt, B., Jonak, Z., Matheny, C.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70426-5
Date:
November, 2014
File:
PDF, 68 KB
english, 2014